Monday, October 8, 2012

Regulatory Convergence and Cooperation to Improve Access and Quality - AsiaReg2013


Asia Regulatory Conference 2013
News &
PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Regulatory Conference Registration Now Available!
To kick off 2013, the Asia Regulatory Conference is bringing together global regulatory professionals to share past experiences and new practices. Don’t miss this exciting event to interact with regulatory and other professionals!
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.

No comments:

Post a Comment